Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B06AC04
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
RUCONEST (AUTHORIZED: ANGIOEDEMAS, HEREDITARY)
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
218406
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
RHUCIN (REFUSED: ANGIOEDEMA)
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
NCI_THESAURUS |
C29726
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/01/036
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
NCI_THESAURUS |
C783
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
WHO-VATC |
QB06AC04
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
218306
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1599831
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL2108350
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
C96366
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
C1 Esterase Inhibitor
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
5QS67N4551
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
5QS67N4551
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
100000115936
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
1599832
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
ALTERNATIVE | |||
|
7627
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
8899
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
DB09228
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
80295-38-1
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
5152
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
SUB22696
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
SUB30787
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | |||
|
m3751
Created by
admin on Mon Mar 31 20:38:09 GMT 2025 , Edited by admin on Mon Mar 31 20:38:09 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY
